A Study of Imatinib and Docetaxel in Prostate Cancer

Clinical trial NCT00251225 · COMPLETED

Trial details

NCT number: NCT00251225
Sponsor: Leonard Appleman
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Prostate Cancer

Start date: 2005-08-01
Primary completion: 2009-03-01
Enrollment: 49

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.